Additional evidence suggests that NKG2D-expressing NK cells or T lymphocytes contribute to tissue damage in MS by killing NKG2D ligand-bearing oligodendrocytes or astrocytes (Saikali et al., 2007). The gene discussed is KLRK1; the disease is myeloid sarcoma.